These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Veno-occlusive disease of the liver induced by gemcitabine. Dobbie M; Hofer S; Oberholzer M; Herrmann R Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086 [No Abstract] [Full Text] [Related]
4. Hemolytic-uremic syndrome caused by gemcitabine. Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169 [No Abstract] [Full Text] [Related]
5. An autopsy case of acute pulmonary toxicity associated with gemcitabine. Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719 [TBL] [Abstract][Full Text] [Related]
7. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer. Chen YM; Liu JM; Tsai CM; Whang-Peng J; Perng RP J Clin Oncol; 1996 May; 14(5):1743-4. PubMed ID: 8622097 [No Abstract] [Full Text] [Related]
8. Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy. Gurumurthy M; Koh P; Singh R; Bhide A; Satodia P; Hocking M; Anbarasu A; Wood LE J Perinatol; 2009 Jan; 29(1):63-5. PubMed ID: 19112460 [TBL] [Abstract][Full Text] [Related]
9. Gemcitabine for lung cancer. Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499 [No Abstract] [Full Text] [Related]
10. Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer. Yildiz R; Coskun U; Kaya AO; Ozturk B; Yaman E Ann Pharmacother; 2007 May; 41(5):901-2. PubMed ID: 17405819 [No Abstract] [Full Text] [Related]
11. An unusual case of gemcitabine-induced radiation recall. Squire S; Chan M; Feller E; Mega A; Gold R Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004 [No Abstract] [Full Text] [Related]
12. Gemcitabine-induced hemolytic uremic syndrome: a case report. Brodowicz T; Breiteneder S; Wiltschke C; Zielinski CC J Natl Cancer Inst; 1997 Dec; 89(24):1895-6. PubMed ID: 9414181 [No Abstract] [Full Text] [Related]
13. [Severe interstitial pneumonitis related to Gemcitabine]. Sabria-Trias J; Bonnaud F; Sioniac M Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953 [TBL] [Abstract][Full Text] [Related]
14. More is better but ... how is best: are milligrams over hours better than grams over minutes? The case of gemcitabine. Pollera CF J Clin Oncol; 1997 May; 15(5):2172-4. PubMed ID: 9164234 [No Abstract] [Full Text] [Related]
16. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993. Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418 [No Abstract] [Full Text] [Related]
17. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis]. Mommens V; Bosquée L; D'Orio V Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer. Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889 [No Abstract] [Full Text] [Related]
20. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy. Banach MJ; Williams GA Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173 [No Abstract] [Full Text] [Related] [Next] [New Search]